BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  GlaxoSmithKline Chairman to Step Down in Two to Three Years

  October 29, 2012

   · 

  1 min read
• Drug Development

  AstraZeneca PLC Begins Global Phase 3 Study of Breast Cancer Faslodex

  October 29, 2012

   · 

  1 min read
• Drug Development

  Celldex Therapeutics, Inc. Makes Significant Advancements in the Field of Protein-Based Vaccine Development

  October 29, 2012

   · 

  1 min read
• Policy

  Orgenesis Presents Technology Update to FDA/CBER Experts

  October 29, 2012

   · 

  1 min read
• Business

  Nordion Restructures Russian Mo-99 Supply Relationship

  October 29, 2012

   · 

  1 min read
• Drug Development

  Arrowhead Research Corporation Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System

  October 29, 2012

   · 

  1 min read
• Drug Development

  Provectus Pharmaceuticals Inc. Presents Nonclinical Data on Antitumor Immune Response to PV-10 Immuno-Chemoablation

  October 29, 2012

   · 

  1 min read
• Business

  Acorda Therapeutics Moves Third Quarter Financial Results Call to Wednesday, October 31, 2012

  October 29, 2012

   · 

  1 min read
• BioMidwest

  Neuros Medical, Inc. Awarded “Most Promising Startup” at 2012 Neurotech Leaders Forum

  October 29, 2012

   · 

  1 min read
• Bio NC

  Precision BioSciences Announces Allowance of Eleventh U.S. Patent Application Related to Genome Editing Nucleases

  October 29, 2012

   · 

  1 min read